Health And Medicine
-
Study finds college athletes more likely to harbor MRSA
College athletes who play contact sports are more than twice as likely to carry the deadly superbug methicillin-resistant Staphylocuccus aureus (MRSA) than peers who play non-contact sports, according to a Vanderbilt study released at IDWeek 2014. Read MoreOct 9, 2014
-
Immune cells that guard against ingested pathogens discovered
Vanderbilt investigators have discovered a new type of immune cell residing in the intestinal epithelium that may function as a first line of defense against ingested pathogens. Read MoreOct 9, 2014
-
Long-range signaling to stem cells
The potential for long-range signaling factors – such as those identified in the current study – to regulate stem cell behaviors has implications in tumor progression and metastasis. Read MoreOct 9, 2014
-
New faculty: Jordan studies sleep disorders in children
As one of the few board-certified pediatric sleep specialists in the region, Atia Jordan works with a multidisciplinary team to address sleep concerns in an effort to improve the overall health and well-being of her patients. Read MoreOct 8, 2014
-
New faculty: Maxwell studies trauma recovery in older population
Working in trauma and critical care for most of her career, Cathy Maxwell noticed profound differences among older patients and their responses to injury. Her curiosity led her to become a nurse researcher in this area. Read MoreOct 3, 2014
-
Low-dose aspirin’s protective effect in cancer explained
For years, scientists have known that regular aspirin use may reduce the risk of cancer. Read MoreOct 2, 2014
-
Traditional healers contribute to HIV care delays: study
If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer. Read MoreOct 2, 2014
-
Team spots key regulator for cholesterol production
A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223. Read MoreOct 2, 2014
-
Regenerative visual neuroscience effort launched
Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries. Read MoreOct 2, 2014
-
Optical imaging in drug therapy screens
A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients. Read MoreOct 1, 2014
-
Seizure mutation impairs receptor
Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures. Read MoreSep 30, 2014
-
Biomarker for diabetic eye disease
A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read MoreSep 26, 2014
-
A path to sarcoidosis treatment
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis. Read MoreSep 25, 2014
-
Alexander’s visit highlights efforts to confront Ebola
Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read MoreSep 24, 2014
-
Study finds accuracy of lung cancer imaging varies by region
A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common. Read MoreSep 24, 2014
-
VU study reveals shared pathways in psychiatric disorders
Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder. Read MoreSep 18, 2014
-
Initiative seeks to develop therapies to combat Ebola
Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. Read MoreSep 18, 2014
-
Heart Institute testing world’s tiniest pacemaker
Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker. Read MoreSep 18, 2014
-
Dioxin, fathers and preterm birth
Exposure of male mice to the pollutant dioxin causes preterm birth across multiple generations, suggesting that efforts to prevent preterm birth should include pre-conception interventions for dads. Read MoreSep 18, 2014
-
Patient-derived stem cells shed light on pulmonary hypertension
Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies. Read MoreSep 16, 2014